Mounjaro Shot: Why It Is Injectable and Format Basics

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Part of the PlexusDx Education Hub, where GLP-1 science, weight-management protocols, and the genetics behind metabolism are covered in plain language. Browse the full Peptides & GLP-1 library.

Type "Mounjaro shot" into a search bar and the underlying question is almost always about format: is this a pill or an injection, what does the delivery method mean day to day, and what does the FDA-approved market actually offer right now. This piece answers the format question factually as of April 2026, then explains why route of administration matters for a molecule like tirzepatide, and where oral options fit into the picture.

What "the Mounjaro shot" really is

Mounjaro (tirzepatide) is available only as a once-weekly subcutaneous injection as of April 2026. There is no oral Mounjaro product currently FDA-approved. The "shot" framing is accurate: for this specific brand, injection is the only route. Lilly's orforglipron, an investigational oral non-peptide small-molecule GLP-1 receptor agonist, has Phase 3 data but is not FDA-approved as of April 2026, so it does not change today's format reality.

Why a peptide like this is injected rather than swallowed

Route is not arbitrary. Peptide drugs are vulnerable to gastric digestion, so injecting them delivers predictable bioavailability. Oral GLP-1 receptor agonists have to survive the stomach; Rybelsus (oral semaglutide) uses an absorption enhancer known as SNAC and requires strict fasting administration to achieve systemic uptake. That is the core reason most incretin therapies, including the Mounjaro shot, are delivered by injection rather than pill.

Injectable and oral incretins side by side

Injectable GLP-1 receptor agonists are typically dosed once weekly, with liraglutide as a daily exception, and offer steady absorption. Oral versions trade that predictability for pill convenience but come with timing and fasting requirements. Head-to-head efficacy data between oral and injectable semaglutide in chronic weight management is limited, and oral semaglutide is labeled for type 2 diabetes rather than weight management. Real-world choice comes down to preference, injection tolerance, timing demands, and lifestyle.

The dose steps the label describes

Reported as label facts rather than instruction: injectable semaglutide titrates from 0.25 mg weekly through higher doses, with Ozempic labeled up to 2 mg and Wegovy up to 2.4 mg. Injectable tirzepatide titrates from 2.5 mg weekly through higher doses, with Mounjaro and Zepbound labeled up to 15 mg. Rybelsus starts at 3 mg daily and titrates to 7 or 14 mg. None of this substitutes for a prescriber's direction.

What PlexusDx offers in each format

Formats are priced and covered separately and may have different savings-program eligibility. PlexusDx provides both routes through its Weight Management Protocols, including Tirzepatide Injection, Tirzepatide Oral, Semaglutide Injection, and Semaglutide Oral, with per-protocol pricing on each product page.

The genetic terrain beneath the needle

Whichever route you and a clinician discuss, the biology underneath stays the same. Variants in FTO, GLP1R, MC4R, and TCF7L2 influence appetite regulation, receptor activity, energy balance, and glucose handling. The PlexusDx Precision Peptide Genetic Test reads that map across 14 pathways, 49 peptides, 150+ genetic insights. It is not pharmacogenomic and never predicts drug response; it is trait-level education that applies whether a compound is delivered orally or by injection.

What the format question is really asking

Underneath "is it a shot or a pill" is usually a practical worry about fit: whether a weekly injection suits a schedule, a comfort level, or a lifestyle. Framing it that way is more useful than treating injection as a drawback to be avoided. The route exists because pharmacology requires it, and the trade-offs between injectable and oral delivery are real but manageable considerations rather than dealbreakers. A clinician can walk through tolerance, timing, and preference alongside the labeled indication for each format. Knowing your own baseline biology adds a further layer to that conversation, describing the metabolic terrain any format acts on, so the choice reflects your situation rather than a generic assumption about what most people prefer.

Frequently Asked Questions

Is there a pill version of Mounjaro?

Not as of April 2026. Rybelsus (oral semaglutide) is the only FDA-approved oral GLP-1 receptor agonist, and it is labeled for type 2 diabetes rather than weight management. There is no FDA-approved oral tirzepatide. PlexusDx does offer separate oral semaglutide and tirzepatide protocols through its Weight Management Protocols.

Why does the Mounjaro shot go under the skin?

Subcutaneous injection gives peptide drugs predictable absorption that swallowing would compromise, since the stomach degrades peptides. Once-weekly dosing keeps receptor engagement steady between injections. The route is a pharmacology decision, not a convenience one, which is why nearly all incretin therapies in this class are injectable.

How does the injection compare with an oral option?

Injections deliver consistent bioavailability with weekly dosing. Oral semaglutide relies on an absorption enhancer and strict fasting administration per its label. Head-to-head weight-management data between the formats is limited, and oral semaglutide is approved for type 2 diabetes, so the two are not simply interchangeable.

Does the genetic test recommend a format?

No. The Precision Peptide Genetic Test does not recommend injection versus oral or predict response to any compound. It analyzes pathway-level variants in genes such as FTO, GLP1R, MC4R, and TCF7L2 that shape baseline metabolism, offering upstream context that holds regardless of delivery route.

Keep reading across the PlexusDx Education Hub. Return to the education library.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.